These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18246050)

  • 1. The spectrum of endometrial pathology induced by progesterone receptor modulators.
    Mutter GL; Bergeron C; Deligdisch L; Ferenczy A; Glant M; Merino M; Williams AR; Blithe DL
    Mod Pathol; 2008 May; 21(5):591-8. PubMed ID: 18246050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator.
    Ioffe OB; Zaino RJ; Mutter GL
    Mod Pathol; 2009 Mar; 22(3):450-9. PubMed ID: 19136935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of progesterone receptor modulators and their effect on the endometrium.
    Spitz IM
    Curr Opin Obstet Gynecol; 2009 Aug; 21(4):318-24. PubMed ID: 19602929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone.
    Fiscella J; Bonfiglio T; Winters P; Eisinger SH; Fiscella K
    Hum Pathol; 2011 Jul; 42(7):947-53. PubMed ID: 21315422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor modulators and the endometrium: changes and consequences.
    Horne FM; Blithe DL
    Hum Reprod Update; 2007; 13(6):567-80. PubMed ID: 17630398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
    Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K
    Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women.
    Dinh A; Sriprasert I; Williams AR; Archer DF
    Contraception; 2015 May; 91(5):360-7. PubMed ID: 25596512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone antagonists and progesterone receptor modulators.
    Spitz IM
    Expert Opin Investig Drugs; 2003 Oct; 12(10):1693-707. PubMed ID: 14519088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endometrial response to modulation of ligand-progesterone receptor pathways is reversible.
    Chodankar RR; Murray A; Nicol M; Whitaker LHR; Williams ARW; Critchley HOD
    Fertil Steril; 2021 Sep; 116(3):882-895. PubMed ID: 33865567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial Effects of Prolonged Therapy with the Selective Progesterone Receptor Modulator Ulipristal Acetate: A Case Report.
    Levy G; Elkas J; Armstrong AY; Nieman LK
    J Reprod Med; 2016; 61(3-4):159-62. PubMed ID: 27172639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium.
    Chwalisz K; Brenner RM; Fuhrmann UU; Hess-Stumpp H; Elger W
    Steroids; 2000; 65(10-11):741-51. PubMed ID: 11108885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology].
    Brazert M; Korman MP; Pawelczyk LA
    Ginekol Pol; 2013 Sep; 84(9):794-800. PubMed ID: 24191519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
    Williams AR; Bergeron C; Barlow DH; Ferenczy A
    Int J Gynecol Pathol; 2012 Nov; 31(6):556-69. PubMed ID: 23018219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial changes during ulipristal acetate use: A systematic review.
    De Milliano I; Van Hattum D; Ket JCF; Huirne JAF; Hehenkamp WJK
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():56-64. PubMed ID: 28482329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective progesterone receptor modulators: future clinical applications].
    Bouchard P; Ouzounian S; Chabbert-Buffet N
    Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human endometrial epithelial telomerase is important for epithelial proliferation and glandular formation with potential implications in endometriosis.
    Valentijn AJ; Saretzki G; Tempest N; Critchley HO; Hapangama DK
    Hum Reprod; 2015 Dec; 30(12):2816-28. PubMed ID: 26498179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial effects of long-term low-dose administration of RU486.
    Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS
    Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.